Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interleukin-1 receptor antagonist inhibits pulmonary hypertension induced by inflammation.

× No keyword cloud information.

9 in total

1. Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner.

Authors: Allan Lawrie; Abdul G Hameed; Janet Chamberlain; Nadine Arnold; Aneurin Kennerley; Kay Hopkinson; Josephine Pickworth; David G Kiely; David C Crossman; Sheila E Francis
Journal: Am J Pathol Date: 2011-08-09 Impact factor: 4.307

2. Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertension.

Authors: David J Ross; Greg Hough; Susan Hama; Jamil Aboulhosn; John A Belperio; Rajan Saggar; Brian J Van Lenten; Abbas Ardehali; Mansoureh Eghbali; Srinivasa Reddy; Alan M Fogelman; Mohamad Navab
Journal: Pulm Circ Date: 2015-12 Impact factor: 3.017

3. Role of the CX3CL1-CX3CR1 axis in chronic inflammatory lung diseases.

Authors: Jianliang Zhang; Jawaharlal M Patel
Journal: Int J Clin Exp Med Date: 2010-08-10

Review 4. Genomics of pulmonary arterial hypertension: implications for therapy.

Authors: Mark W Geraci; Todd M Bull; Rubin M Tuder
Journal: Heart Fail Clin Date: 2010-01 Impact factor: 3.179

5. IL-32-dependent effects of IL-1beta on endothelial cell functions.

Authors: Claudia A Nold-Petry; Marcel F Nold; Jarod A Zepp; Soo-Hyun Kim; Norbert F Voelkel; Charles A Dinarello
Journal: Proc Natl Acad Sci U S A Date: 2009-02-19 Impact factor: 11.205

6. Pulmonary hypertension can be a sequela of prior Pneumocystis pneumonia.

Authors: Steve D Swain; Soo Han; Ann Harmsen; Katie Shampeny; Allen G Harmsen
Journal: Am J Pathol Date: 2007-07-19 Impact factor: 4.307

7. Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling.

Authors: Josephine Pickworth; Alexander Rothman; James Iremonger; Helen Casbolt; Kay Hopkinson; Peter M Hickey; Santhi Gladson; Sheila Shay; Nicholas W Morrell; Sheila E Francis; James D West; Allan Lawrie
Journal: Pulm Circ Date: 2017-09-22 Impact factor: 3.017

8. Interleukin-1 Receptor Antagonist Protects Newborn Mice Against Pulmonary Hypertension.

Authors: Christine B Bui; Magdalena Kolodziej; Emma Lamanna; Kirstin Elgass; Arvind Sehgal; Ina Rudloff; Daryl O Schwenke; Hirotsugu Tsuchimochi; Maurice A G M Kroon; Steven X Cho; Anton Maksimenko; Marian Cholewa; Philip J Berger; Morag J Young; Jane E Bourke; James T Pearson; Marcel F Nold; Claudia A Nold-Petry
Journal: Front Immunol Date: 2019-07-11 Impact factor: 7.561

9. Chronic intermittent hypobaric hypoxia attenuates monocrotaline-induced pulmonary arterial hypertension via modulating inflammation and suppressing NF-κB/p38 pathway.

Authors: Lei Gao; Jun Liu; Yongmei Hao; Zengren Zhao; Huilian Tan; Jie Zhang; Ning Meng; Qinghou Zheng; Zhen Wang; Yi Zhang
Journal: Iran J Basic Med Sci Date: 2018-03 Impact factor: 2.699

9 in total